We use cookies for a better user experience. Read our Privacy Policy

I Agree

Plaque Modification Devices Market

Plaque Modification Devices Market (Product Type: Atherectomy Devices, Thrombectomy Devices, Chronic Total Occlusion (CTO) Devices, and Embolic Protection Devices (EPD); Application: Coronary Artery Disease, Peripheral Artery Disease, Neurovascular Disease, and Others; and End User: Hospitals, Specialty Clinics, and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Coronary Lithoplasty Gains Recognition as Effective Technique for Severe Coronary Calcium

The high prevalence of severe coronary calcium among individuals has triggered the demand for plaque modification devices. As such, non-balloon and balloon-based technologies are gaining importance in the management of severe calcified lesions. Moreover, the availability of new devices are boosting growth of the plaque modification devices market, which is anticipated to reach a revenue of ~US$ 2.1 Bn by the end of 2027. Hence, healthcare companies are increasing their R&D in lithoplasty balloon that involves the use of high-energy mechanical pulses to crack coronary calcium.

Coronary lithoplasty is acquiring popularity as an easy and effective technique to alleviate deep calcium in the plaque modification devices market. Thus, advantages of coronary lithoplasty are anticipated to revolutionize the management of severe calcified coronary lesions. In order to support this trend, healthcare providers are growing increasingly aware about intravascular imaging that helps clinicians to opt for the most appropriate plaque modification devices. Novel imaging techniques help clinicians to analyze the optimal stent result.

plaque modification devices market infographic

To know the scope of our report Get a Sample on Plaque Modification Devices Market 

Atherectomy Devices a Superior Solution for Treatment of Peripheral Artery Diseases

Innovations in atherectomy devices are expected to bring about a change in the plaque modification devices market. For instance, Avinger Inc.— a commercial-stage medical device company, announced the FDA clearance for its next-gen Pantheris Lumivascular atherectomy system. This explains why atherectomy devices product type segment is estimated to lead the plaque modification devices market.

Companies in the plaque modification devices market are increasing research to develop innovative image-guided atherectomy devices for the treatment of peripheral artery diseases. Likewise, the lumivascular technology is being highly publicized for real-time intravascular imaging and is being combined with highly effective catheters for management of peripheral artery diseases. As such, companies in the market for plaque modification devices are tapping opportunities in North America due to the high prevalence of peripheral artery diseases in the U.S. They are increasing efficacy to make design improvements in atherectomy devices with the help of simplified single balloon system.

Get a glimpse of the in-depth analysis through our Report Brochure

Intravascular Ultrasound and Preintervention OCT Imaging Help Prevent Stent Failure

Optimal coronary stent implantation is found to be among the few successful strategies that prevent stent failures. However, there is a growing need for increased understanding of the intravascular milieu for optimization of percutaneous coronary intervention (PCI). Hence, companies are taking efforts to gain an understanding about intravascular ultrasound and optical coherence tomography (OCT) that offers insights on calcium thickness.

The plaque modification devices market is expected to expand at a striking CAGR of ~8% during the forecast period. As such, the success of plaque modification devices is highly dependent on OCT-rendered evaluation of cross-sectional calcium distribution. Likewise, preintervention OCT imaging provides accurate measurements to healthcare providers about the minimal lumen area and lesion length. Thus, innovative imaging techniques are bolstering the growth of the plaque modification devices market. Preintervention OCT imaging is generating incremental opportunities for companies in the market for plaque modification devices, since the technique is used for procedural planning and stent sizing.

Expanding operations in future? To get the perfect launch ask for a custom report

Precision Dilation and Superior Compliance Spur Demand for Advanced Dilation Devices

Companies in the plaque modification devices market are developing devices that treat complex lesions. For instance, Boston Scientific— a U.S.-based manufacturer of medical devices for interventional medical specialties, has a broad product portfolio in plaque modification devices such as the Flextome™ Cutting Balloon™ Dilatation Device. Manufacturers are developing novel devices that help clinicians in treating resistant lesions. They are making product improvements with nylon balloon materials designed to offer flexibility and enhanced puncture resistance.

Precision dilation and superior compliance are key focus points for companies in the plaque modification devices market. On the other hand, manufacturers are innovating in rotational atherectomy devices. Manufacturers are increasing their production capacities to develop rotational atherectomy devices that are gaining global recognition. Rotational atherectomy devices help to successfully ablate calcium in coronary arteries. Likewise, these novel devices are gaining popularity in conducting safe ablation. Manufacturers are increasing research to offer precise control in order to selectively ablate calcium, whilst preserving the elastic tissue of the vessel wall.

plaque modification devices market segmentation

Analysts’ Viewpoint

The expansion of product portfolio in atherectomy devices creates revenue streams for companies in the plaque modification devices market. As such, companies are aiming at FDA clearance of devices to bolster their credibility in the global landscape. Stable rotation and size flexibility are increasingly becoming the key focus points in the development of rotational atherectomy devices.

Coronary lithoplasty is gaining importance as an effective technique for the treatment of severe coronary calcium. However, difficult device delivery and suboptimal stent expansion are some of the restraints that are likely to slow down market growth. Hence, companies should increase awareness about preintervention OCT imaging that helps physicians to select optimum plaque modification strategy prior to stent implantation.

Plaque Modification Devices Market: Overview

  • The global plaque modification devices market was valued at ~US$ 1.1 Bn in 2018 and is projected to expand at a rapid pace from 2019 to 2027. Rise in atherosclerosis conditions; increase in patient pool suffering from coronary, peripheral, and other cardiac diseases; rise in geriatric population; growth in hypertension condition in adult and pediatric patient; approval of novel plaque removal techniques; and increase in awareness about atherosclerosis conditions and their treatment, especially in developing markets, are anticipated to fuel the global plaque modification devices market.
  • Atherosclerosis is a disease, wherein plaque builds inside arteries that carry blood to the brain, heart, and other body parts. Plaque is a deposition of the fats, cholesterol, calcium, and other substances that create blockage in arteries. This is a primary cause of developing coronary, peripheral, and other cardiac diseases. Plaque deposition can lead to heart stroke. Plaques rupture leads to occlusion in the artery by developing clot. Treatments for plaque include procedures to remove or open blockages in arteries, and medication. According to research published on NCBI (National Center for Biotechnology Information), in 2019, in reference to a study conducted on myocardial infarction patients, 60% of myocardial patients died due to plaque ruptures and rest 40% due to superficial erosion. The study concluded that plaque deposition is a growing cause of death among cardiac patients.
  • Launch of various innovative devices used in the atherosclerosis or plaque removal is likely to present multiple choices to the surgeons. Several companies such as Boston scientific Corporation and B Braun Melsungen, Avinger provide a wide range of plaque modification devices. These companies aim to launch products with advanced technologies. For instance, Avinger plans to launch Ocelaris CAD, a groundbreaking image guided CTO crossing in 2021. The launch of Pantheris Next Generation and Pantheris SV in 2018 and 2019, respectively, is expected to provide lucrative opportunities for the company.

Plaque Modification Devices Market: Segmentation

  • The global plaque modification devices market has been segmented based on product type, application, end user, and region
  • In terms of product type, the global plaque modification devices market has been classified into atherectomy devices, thrombectomy devices, chronic total occlusion devices, and embolic protection devices. The atherectomy devices segment is projected to expand at a rapid pace during the forecast period. The segment includes different types of novel technologies, such as directional, orbital, and rotational, that are used in the treatment of plaque. Various companies operating in the plaque modification devices market have launched devices that cater to the image guided technology.
  • Based on application, the global plaque modification devices market has been divided into coronary artery diseases, peripheral artery diseases, neurovascular diseases, and others. The coronary artery diseases segment accounted for significant share of the plaque modification devices market in 2018. It was followed by the peripheral artery diseases segment. Rise in minimally invasive surgeries, including atherectomy, thrombectomy, and chronic total occlusion, is likely to drive the demand for plaque modification devices. 
  • In terms of end user, the global plaque modification devices market has been segregated into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment dominated the global plaque modification devices market in 2018, owing to introduction of technologically innovative modules in hospitals, favorable reimbursement policies, and availability of expertise and hospital-based health care system in most geographies.

Plaque Modification Devices Market: Regional Segmentation

  • In terms of region, the global plaque modification devices market has been split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global plaque modification devices market in 2018, owing to the increase in prevalence of atherosclerosis, hypertension, and cardiac diseases in the region. Technological advancement is a major factor boosting the development of technically advanced devices for plaque removal. Advancement in healthcare infrastructure and approval of plaque incision systems, exclusively by the U.S. FDA (U.S. Food and Drug Administration), are likely to propel the plaque modification devices market in North America. Rise in adoption of minimal invasive surgeries, high prevalence of hypertension, and investments by key players in R&D to incorporate multiple functional utilities in devices are estimated to boost the plaque modification devices market in the region.
  • The plaque modification devices market in Asia Pacific is anticipated to expand at a faster pace than that in other regions during the forecast period, owing to the increase in prevalence of plaque deposition, and cardiovascular and hypertension conditions in the region. Rise in incidences of heart diseases in geriatric population, faster adoption of minimally invasive surgeries, and increase in patient population are also likely to drive the demand for plaque modification devices. Presence of key players in the region offering innovative thrombectomy and embolic protection devices for accurate removal of thrombus or clots is expected to propel the plaque modification devices market in Asia Pacific.
  • The plaque modification devices market in Latin America and Middle East & Africa is anticipated to expand at a considerable pace due to the increase in patient pool suffering from cardiovascular diseases and rise in focus on creating awareness about atherosclerosis treatment in these regions

Plaque Modification Devices Market: Major Players

  • Key players operating in the global plaque modification devices market include
    • Boston Scientific Corporation,
    • B. Braun Melsungen,
    • BD (Becton,
    • Dickinson and Company),
    • Cardinal Health,
    • Medtronic,
    • Cardiovascular Systems Inc.,
    • Microvention, Inc. (Terumo ),
    • Penumbra, Inc.,
    • Biotronik,
    • Stryker, a
    • Codman Neuro (Johnson & Johnson)
  • These players are focused on adopting organic and inorganic growth strategies to strengthen product portfolio and expand their alliances with other companies. Key players have adopted strategies such as expansion of geographic footprint, collaborations & acquisitions, launch of innovative atherosclerosis removal techniques, investment in research & development activities, and launch of image guided CTO products in order to be competitive in the global plaque modification devices market.

Plaque Modification Devices Market - Segmentation

Product Type

  • Atherectomy Devices 
  • Thrombectomy Devices 
  • Chronic Total Occlusion (CTO) Devices
  • Embolic Protection Devices (EPD)

Application

  • Coronary Artery Disease
  • Peripheral Artery Disease
  • Neurovascular Disease
  • Others

End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Plaque Modification Devices Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of plaque modification devices market?

Plaque modification devices market to reach a revenue of ~US$ 2.1 Bn by 2027

What are the key driving factors for the growth of the plaque modification devices market?

Plaque modification devices market is driven by rise in prevalence of atherosclerosis, coronary & peripheral artery diseases, and hypertension

Which region is expected to project the highest market share in the global plaque modification devices market?

North America accounted for major share of the global plaque modification devices market owing to the increase in prevalence of atherosclerosis

Which is the rising prominent segment in the plaque modification devices market?

The coronary artery diseases segment accounted for significant share of the plaque modification devices market

Who are the key players in the global plaque modification devices market?

Key players in the global plaque modification devices market include Boston Scientific Corporation, B. Braun Melsungen, Becton, Dickinson and Company, Cardinal Health, Medtronic

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Plaque Modification Devices Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Plaque Modification Devices Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Technological Advancements

    5.2. Disease Prevalence & Incidence Rate globally with Key countries

    5.3. Reimbursement Scenario, by Region/globally

    5.4. Growing Minimal Invasive Surgeries

6. Global Plaque Modification Devices Market Analysis and Forecast, by Product Type  

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027

        6.3.1. Atherectomy Devices  

        6.3.2. Thrombectomy Devices  

        6.3.3. Chronic Total Occlusion (CTO) Devices  

        6.3.4. Embolic Protection Devices (EPD)

    6.4. Market Attractiveness Analysis, by Product Type  

7. Global Plaque Modification Devices Market Analysis and Forecast, by Application 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Plaque Modification Devices Market Value Forecast, by Application, 2017–2027

        7.3.1. Coronary Artery Disease 

        7.3.2. Peripheral Artery Disease

        7.3.3. Neurovascular Disease

        7.3.4. Others

    7.4. Market Attractiveness Analysis, by Application 

8. Global Plaque Modification Devices Market Analysis and Forecast, by End-user 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027

        8.3.1. Hospitals 

        8.3.2. Specialty Clinics

        8.3.3. Ambulatory Surgical Centers 

    8.4. Market Attractiveness Analysis, by End-user

9. Global Plaque Modification Devices Market Analysis and Forecast, by Region 

    9.1. Key Findings

    9.2. Plaque Modification Devices Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe 

        9.2.3. Asia Pacific

        9.2.4. Latin America 

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Plaque Modification Devices Market Analysis and Forecast

    10.1.  Introduction

        10.1.1.  Key Findings

    10.2.  North America Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027

        10.2.1. Atherectomy Devices  

        10.2.2. Thrombectomy Devices  

        10.2.3. Chronic Total Occlusion (CTO) Devices  

        10.2.4. Embolic Protection Devices (EPD)

    10.3.  North America Plaque Modification Devices Market Value Forecast, by Application , 2017–2027

        10.3.1. Coronary Artery Disease 

        10.3.2. Peripheral Artery Disease

        10.3.3. Neurovascular Disease

        10.3.4. Others

    10.4. North America Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027

        10.4.1. Hospitals

        10.4.2. Specialty Clinics

        10.4.3. Ambulatory Surgical Centers 

    10.5. North America Plaque Modification Devices Market Value Forecast, by Country/Sub-region, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Plaque Modification Devices Market Attractiveness Analysis

        10.6.1. By Product Type  

        10.6.2. By Application 

        10.6.3. By End-user 

        10.6.4. By Country

11. Europe Plaque Modification Devices Market Analysis and Forecast

    11.1.  Introduction

        11.1.1.  Key Findings

    11.2. Europe Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027

        11.2.1. Atherectomy Devices  

        11.2.2. Thrombectomy Devices  

        11.2.3. Chronic Total Occlusion (CTO) Devices  

        11.2.4. Embolic Protection Devices (EPD)

    11.3. Europe Plaque Modification Devices Market Value Forecast, by Application, 2017–2027

        11.3.1. Coronary Artery Disease 

        11.3.2. Peripheral Artery Disease

        11.3.3. Neurovascular Disease

        11.3.4. Others

    11.4. Europe Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027

        11.4.1. Hospitals

        11.4.2. Specialty Clinics

        11.4.3. Ambulatory Surgical Centers 

    11.5. Europe Plaque Modification Devices Market Value Forecast, by Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Plaque Modification Devices Market Attractiveness Analysis

        11.6.1. By Product Type  

        11.6.2. By Application 

        11.6.3. By End-user 

        11.6.4. By Country/Sub-region

12. Asia Pacific Plaque Modification Devices Market Analysis and Forecast

    12.1.  Introduction

        12.1.1.  Key Findings

    12.2.  Asia Pacific Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027

        12.2.1. Atherectomy Devices  

        12.2.2. Thrombectomy Devices  

        12.2.3. Chronic Total Occlusion (CTO) Devices  

        12.2.4. Embolic Protection Devices (EPD)

    12.3.  Asia Pacific Plaque Modification Devices Market Value Forecast, by Application, 2017–2027

        12.3.1. Coronary Artery Disease 

        12.3.2. Peripheral Artery Disease

        12.3.3. Neurovascular Disease

        12.3.4. Others

    12.4. Asia Pacific Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027

        12.4.1. Hospitals 

        12.4.2. Specialty Clinics

        12.4.3. Ambulatory Surgical Centers 

    12.5. Asia Pacific Plaque Modification Devices Market Value Forecast, by Country/Sub-region, 2017–2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Plaque Modification Devices Market Attractiveness Analysis

        12.6.1. By Product Type  

        12.6.2. By Application 

        12.6.3. By End-user 

        12.6.4. By Country/Sub-region

13. Latin America Plaque Modification Devices Market Analysis and Forecast

    13.1.  Introduction

        13.1.1.  Key Findings

    13.2.  Latin America Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027

        13.2.1. Atherectomy Devices  

        13.2.2. Thrombectomy Devices  

        13.2.3. Chronic Total Occlusion (CTO) Devices  

        13.2.4. Embolic Protection Devices (EPD)

    13.3. Latin America Plaque Modification Devices Market Value Forecast, by Application, 2017–2027

        13.3.1. Coronary Artery Disease 

        13.3.2. Peripheral Artery Disease

        13.3.3. Neurovascular Disease

        13.3.4. Others

    13.4. Latin America Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027

        13.4.1. Hospitals

        13.4.2. Specialty Clinics

        13.4.3. Ambulatory Surgical Centers 

    13.5. Latin America Plaque Modification Devices Market Value Forecast, by Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Plaque Modification Devices Market Attractiveness Analysis

        13.6.1. By Product Type  

        13.6.2. By Application 

        13.6.3. By End-user 

        13.6.4. By Country/Sub-region

14. Middle East & Africa Plaque Modification Devices Market Analysis and Forecast

    14.1.  Introduction

        14.1.1.  Key Findings

    14.2.  Middle East & Africa Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027

        14.2.1. Atherectomy Devices  

        14.2.2. Thrombectomy Devices  

        14.2.3. Chronic Total Occlusion (CTO) Devices  

        14.2.4. Embolic Protection Devices (EPD) 

    14.3.  Middle East & Africa Plaque Modification Devices Market Value Forecast, by Application, 2017–2027

        14.3.1. Coronary Artery Disease 

        14.3.2. Peripheral Artery Disease

        14.3.3. Neurovascular Disease

        14.3.4. Others

    14.4. Middle East & Africa Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027

        14.4.1. Hospitals

        14.4.2. Specialty Clinics

        14.4.3. Ambulatory Surgical Centers 

    14.5. Middle East & Africa Plaque Modification Devices Market Value Forecast, by Country/Sub-region, 2017–2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Plaque Modification Devices Market Attractiveness Analysis

        14.6.1. By Product Type  

        14.6.2. By Application 

        14.6.3. By End-user 

        14.6.4. By Country/Sub-region

15. Competitive Landscape

    15.1.  Market Share Analysis, by Company, 2018

    15.2.  Company Profiles

        15.2.1. Boston Scientific Corporation 

            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.1.2. Financial Overview 

            15.2.1.3. Product Portfolio

            15.2.1.4. Strategic Overview

            15.2.1.5. SWOT Analysis

        15.2.2. B. Braun Melsungen 

            15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.2.2. Financial Overview

            15.2.2.3. Product Portfolio

            15.2.2.4. Strategic Overview

            15.2.2.5. SWOT Analysis

        15.2.3. Becton, Dickinson and Company 

            15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.3.2. Financial Overview

            15.2.3.3. Product Portfolio

            15.2.3.4. Strategic Overview

            15.2.3.5. SWOT Analysis

        15.2.4. Cardinal Health

            15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.4.2. Financial Overview

            15.2.4.3. Product Portfolio

            15.2.4.4. Strategic Overview

            15.2.4.5. SWOT Analysis

        15.2.5. Medtronic

            15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.5.2. Financial Overview

            15.2.5.3. Product Portfolio

            15.2.5.4. Strategic Overview

            15.2.5.5. SWOT Analysis

        15.2.6. Cardiovascular Systems, Inc.

            15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.6.2. Financial Overview

            15.2.6.3. Product Portfolio

            15.2.6.4. Strategic Overview

            15.2.6.5. SWOT Analysis

        15.2.7. Microvention, Inc. (Terumo)

            15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.7.2. Financial Overview

            15.2.7.3. Product Portfolio

            15.2.7.4. Strategic Overview

            15.2.7.5. SWOT Analysis

        15.2.8.  Penumbra, Inc.

            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.8.2. Financial Overview

            15.2.8.3. Product Portfolio

            15.2.8.4. Strategic Overview

            15.2.8.5. SWOT Analysis

        15.2.9.  Biotronik

            15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.9.2. Financial Overview

            15.2.9.3. Product Portfolio

            15.2.9.4. Strategic Overview

            15.2.9.5. SWOT Analysis

        15.2.10.  Stryker

            15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.10.2. Financial Overview

            15.2.10.3. Product Portfolio

            15.2.10.4. Strategic Overview

            15.2.10.5. SWOT Analysis

        15.2.11.  Codman Neuro (Johnson & Johnson)

            15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.11.2. Financial Overview

            15.2.11.3. Product Portfolio

            15.2.11.4. Strategic Overview

            15.2.11.5. SWOT Analysis

List of Tables

Table 01: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 02: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 03: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 04: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 05: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 06: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 07: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 08: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 09: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 10: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 11: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 12: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 13: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 14: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 15: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 17: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 18: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 19: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 20: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 21: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 22: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 23: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 24: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 25: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 26: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 27: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 28: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 29: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 30: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

List of Figures

Figure 01 : Global Plaque Modification Devices Market Snapshot

Figure 02: Global Plaque Modification Devices Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 03: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, 2017?2027

Figure 04: Global Plaque Modification Devices Market Value Share, by Product Type , 2018

Figure 05: Global Plaque Modification Devices Market Value Share, by Application, 2018

Figure 06: Global Plaque Modification Devices Market Value Share, by End-user, 2018

Figure 07: Global Plaque Modification Devices Market Value Share, by Region, 2018

Figure 08: Global Plaque Modification Devices Market Value Share Analysis, by Product Type , 2018 and 2027

Figure 09: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Atherectomy Devices , 2017–2027

Figure 10: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Thrombectomy Devices , 2017–2027

Figure 11: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Chronic Total Occlusion, 2017–2027

Figure 12: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Embolic Protection, 2017–2027

Figure 13: Global Plaque Modification Devices Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 14: Global Plaque Modification Devices Market Value Share Analysis, by Application, 2018 and 2027

Figure 15: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Coronary Disease, 2017–2027

Figure 16: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Peripheral Artery Disease, 2017–2027

Figure 17: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Neurovascular Disease, 2017–2027

Figure 18: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027

Figure 19: Global Plaque Modification Devices Market Attractiveness Analysis, by Application, 2019–2027

Figure 20 : Global Plaque Modification Devices Market Value Share Analysis, by End-user, 2018 and 2027

Figure 21: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2017–2027

Figure 22: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Specialty Clinics, 2017–2027

Figure 23: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgical Centers, 2017–2027

Figure 24: Global Plaque Modification Devices Market Attractiveness Analysis, by End-user, 2019–2027

Figure 25: Global Plaque Modification Devices Market Snapshot, by Country/Sub-region

Figure 26: Global Plaque Modification Devices Market Value Share Analysis, by Region 2018 and 2027

Figure 27: Global Plaque Modification Devices Market Attractiveness Analysis, by Region, 2019–2027

Figure 28: North America Plaque Modification Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 29: North America Plaque Modification Devices Market Value Share (%), by Product Type , 2018 and 2027

Figure 30: North America Plaque Modification Devices Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 31: North America Plaque Modification Devices Market Value Share (%), by Application, 2018 and 2027

Figure 32: North America Plaque Modification Devices Market Attractiveness Analysis, by Application, 2019–2027

Figure 33 : North America Plaque Modification Devices Market Value Share (%), by End-user, 2018 and 2027

Figure 34: North America Plaque Modification Devices Market Attractiveness Analysis, by End-user, 2019–2027

Figure 35: North America Plaque Modification Devices Market Value Share (%), by Country, 2018 and 2027

Figure 36: North America Plaque Modification Devices Market Attractiveness Analysis, by Country, 2019–2027

Figure 37: Europe Plaque Modification Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 38: Europe Plaque Modification Devices Market Value Share (%), by Product Type , 2018 and 2027

Figure 39: Europe Plaque Modification Devices Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 40: Europe Plaque Modification Devices Market Value Share (%), by Application, 2018 and 2027

Figure 41: Europe Plaque Modification Devices Market Attractiveness Analysis, by Application, 2019–2027

Figure 42: Europe Plaque Modification Devices Market Value Share (%), by End-user, 2018 and 2027

Figure 43: Europe Plaque Modification Devices Market Attractiveness Analysis, by End-user, 2019–2027

Figure 44: Europe Plaque Modification Devices Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 45: Europe Plaque Modification Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 46: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 47: Asia Pacific Plaque Modification Devices Market Value Share (%), by Product Type , 2018 and 2027

Figure 48: Asia Pacific Plaque Modification Devices Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 49: Asia Pacific Plaque Modification Devices Market Value Share (%), by Application, 2018 and 2027

Figure 50: Asia Pacific Plaque Modification Devices Market Attractiveness Analysis, by Application, 2019–2027

Figure 51: Asia Pacific Plaque Modification Devices Market Value Share (%), by End-user, 2018 and 2027

Figure 52: Asia Pacific Plaque Modification Devices Market Attractiveness Analysis, by End-user, 2019–2027

Figure 53: Asia Pacific Plaque Modification Devices Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 54: Asia Pacific Plaque Modification Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 55: Latin America Plaque Modification Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 56: Latin America Plaque Modification Devices Market Value Share (%), by Product Type , 2018 and 2027

Figure 57: Latin America Plaque Modification Devices Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 58: Latin America Plaque Modification Devices Market Value Share (%), by Application, 2018 and 2027

Figure 59: Latin America Plaque Modification Devices Market Attractiveness Analysis, by Application, 2019–2027

Figure 60: Latin America Plaque Modification Devices Market Value Share (%), by End-user, 2018 and 2027

Figure 61: Latin America Plaque Modification Devices Market Attractiveness Analysis, by End-user, 2019–2027

Figure 62: Latin America Plaque Modification Devices Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 63: Latin America Plaque Modification Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 64: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 65 : Middle East & Africa Plaque Modification Devices Market Value Share (%), by Product Type , 2018 and 2027

Figure 66: Middle East & Africa Plaque Modification Devices Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 67 : Middle East & Africa Plaque Modification Devices Market Value Share (%), by Application, 2018 and 2027

Figure 68: Middle East & Africa Plaque Modification Devices Market Attractiveness Analysis, by Application, 2019–2027

Figure 69 : Middle East & Africa Plaque Modification Devices Market Value Share (%), by End-user, 2018 and 2027

Figure 70: Middle East & Africa Plaque Modification Devices Market Attractiveness Analysis, by End-user, 2019–2027

Figure 71 : Middle East & Africa Plaque Modification Devices Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 72: Middle East & Africa Plaque Modification Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

585

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved